{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:02:47Z","timestamp":1762459367521},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00592-016-0868-7","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T06:38:42Z","timestamp":1463553522000},"page":"761-767","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence and correlated factors of beta cell failure in a 4-year follow-up of patients with type 2 diabetes: a longitudinal analysis of the BETADECLINE study"],"prefix":"10.1007","volume":"53","author":[{"given":"Carlo B.","family":"Giorda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cercone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"868_CR1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2337\/diabetes.50.6.1290","volume":"50","author":"M Federici","year":"2001","unstructured":"Federici M, Hribal M, Perego L et al (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50:1290\u20131301","journal-title":"Diabetes"},{"key":"868_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4239\/wjd.v6.i1.109","volume":"6","author":"Y Saisho","year":"2015","unstructured":"Saisho Y (2015) \u03b2-cell dysfunction: its critical role in prevention and management of type 2 diabetes. World J Diabetes 6:109\u2013124","journal-title":"World J Diabetes"},{"key":"868_CR3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","volume":"44","author":"UK Prospective","year":"1995","unstructured":"Prospective UK (1995) Diabetes Study Group. UK prospective diabetes study 16. Overview of 6\u00a0years\u2019 therapy of type II diabetes: a progressive disease. Diabetes 44:1249\u20131258","journal-title":"Diabetes"},{"key":"868_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2213-8587(13)70006-8","volume":"1","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Retnakaran R (2013) Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 1:28\u201334","journal-title":"Lancet Diabetes Endocrinol"},{"key":"868_CR5","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0906471106","volume":"106","author":"R Guardado-Mendoza","year":"2009","unstructured":"Guardado-Mendoza R, Davalli AM, Chavez AO et al (2009) Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci USA 106:13992\u201313997","journal-title":"Proc Natl Acad Sci USA"},{"key":"868_CR6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/meta.2002.35200","volume":"51","author":"S Piro","year":"2002","unstructured":"Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340\u20131347","journal-title":"Metabolism"},{"key":"868_CR7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","volume":"307","author":"CJ Rhodes","year":"2005","unstructured":"Rhodes CJ (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307:380\u2013384","journal-title":"Science"},{"key":"868_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.biocel.2006.09.007","volume":"39","author":"SC Lee","year":"2007","unstructured":"Lee SC, Pervaiz S (2007) Apoptosis in the pathophysiology of diabetes mellitus. Int J Biochem Cell Biol 39:497\u2013504","journal-title":"Int J Biochem Cell Biol"},{"key":"868_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107","journal-title":"Nat Rev Immunol"},{"key":"868_CR10","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1210\/jc.2010-0668","volume":"95","author":"JL Leahy","year":"2010","unstructured":"Leahy JL, Hirsch IB, Peterson KA, Schneider D (2010) Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab 95:4206\u20134216","journal-title":"J Clin Endocrinol Metab"},{"key":"868_CR11","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","volume":"178","author":"SE Kahn","year":"2011","unstructured":"Kahn SE, Cooper ME, Del Prato S (2011) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Am J Pathol 178:2632\u20132640","journal-title":"Am J Pathol"},{"issue":"10","key":"868_CR12","doi-asserted-by":"crossref","first-page":"e109702","DOI":"10.1371\/journal.pone.0109702","volume":"9","author":"GT Russo","year":"2014","unstructured":"Russo GT, Giorda CB, Cercone S, Nicolucci A (2014) Cucinotta D; BetaDecline Study Group. Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study. PLoS One 9(10):e109702","journal-title":"PLoS One"},{"key":"868_CR13","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","volume":"355","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Haffner SM, Heise MA et al (2006) ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427\u20132443","journal-title":"N Engl J Med"},{"key":"868_CR14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1997","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183\u20131197","journal-title":"Diabetes Care"},{"key":"868_CR15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/ijcp.12154","volume":"67","author":"S Mudaliar","year":"2013","unstructured":"Mudaliar S (2013) Choice of early treatment regimen and impact on \u03b2-cell preservation in type 2 diabetes. Int J Clin Pract 67:876\u2013887","journal-title":"Int J Clin Pract"},{"key":"868_CR16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11892-014-0492-2","volume":"14","author":"RB Sharma","year":"2014","unstructured":"Sharma RB, Alonso LC (2014) Lipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well? Curr Diabetes Rep 14:492","journal-title":"Curr Diabetes Rep"},{"key":"868_CR17","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1210\/en.2003-0410","volume":"144","author":"W El-Assaad","year":"2003","unstructured":"El-Assaad W, Buteau J, Peyot ML et al (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144:4154\u20134163","journal-title":"Endocrinology"},{"key":"868_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00592-013-0543-1","volume":"51","author":"G Daniele","year":"2014","unstructured":"Daniele G, Guardado Mendoza R et al (2014) The inflammatory status score including IL-6, TNF-\u03b1, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51:123\u2013131","journal-title":"Acta Diabetol"},{"key":"868_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00439-003-0912-x","volume":"112","author":"B Vozarova","year":"2003","unstructured":"Vozarova B, Fern\u00e1ndez-Real JM, Knowler WC et al (2003) The interleukin-6 (\u2212174) G\/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 112:409\u2013413","journal-title":"Hum Genet"},{"key":"868_CR20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/07853890802337037","volume":"41","author":"C Huth","year":"2009","unstructured":"Huth C, Illig T, Herder C et al (2009) Joint analysis of individual participants\u2019 data from 17 studies on the association of the IL6 variant \u2212174G\u00a0>\u00a0C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med 41:128\u2013138","journal-title":"Ann Med"},{"key":"868_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00421-010-1362-5","volume":"109","author":"D Hansen","year":"2010","unstructured":"Hansen D, Dendale P, Beelen M et al (2010) Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol 109:397\u2013404","journal-title":"Eur J Appl Physiol"},{"key":"868_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diabet.2014.08.006","volume":"40","author":"M Hanefeld","year":"2014","unstructured":"Hanefeld M (2014) Use of insulin in type 2 diabetes: what we learned from recent clinical trials on the benefits of early insulin initiation. Diabetes Metab 40:391\u2013399","journal-title":"Diabetes Metab"},{"key":"868_CR23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11892-013-0363-2","volume":"13","author":"KA Page","year":"2013","unstructured":"Page KA, Reisman T (2013) Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes. Curr Diabetes Rep 13:252\u2013260","journal-title":"Curr Diabetes Rep"},{"key":"868_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabet.2015.03.007","volume":"41","author":"P Valensi","year":"2015","unstructured":"Valensi P, de Pouvourville G, Benard N et al (2015) Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes: the ODYSSEE observational study. Diabetes Metab 41:231\u2013238","journal-title":"Diabetes Metab"},{"key":"868_CR25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(13)60683-2","volume":"382","author":"WT Cefalu","year":"2013","unstructured":"Cefalu WT, Leiter LA, Yoon KH et al (2013) Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52\u00a0week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet 382:941\u2013950","journal-title":"Lancet"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-016-0868-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0868-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T23:23:35Z","timestamp":1600557815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-016-0868-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s00592-016-0868-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}